###begin article-title 0
###xml 19 24 <span type="species:ncbi:9606">Human</span>
###xml 56 63 <span type="species:ncbi:1392">Anthrax</span>
Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry
###end article-title 0
###begin p 1
Conceived and designed the experiments: JY PR. Performed the experiments: PR. Analyzed the data: PR. Wrote the paper: JY PR.
###end p 1
###begin p 2
###xml 41 48 <span type="species:ncbi:1392">anthrax</span>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 325 332 <span type="species:ncbi:1392">anthrax</span>
###xml 426 433 <span type="species:ncbi:1392">anthrax</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 717 724 <span type="species:ncbi:1392">anthrax</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
###xml 846 853 <span type="species:ncbi:1392">anthrax</span>
The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout mice demonstrated no role for either LRP6 or the related LRP5 protein in anthrax toxin entry. One possible explanation for this discrepancy is that LRP6 may be important for anthrax toxin entry into human, but not mouse, cells. To test this idea we have investigated the effect of knocking down LRP6 or LRP5 expression with siRNAs in human HeLa cells. We show here that efficient knockdown of either LRP6, LRP5, or both proteins has no influence on the kinetics of anthrax lethal toxin entry or MEK1 substrate cleavage in these cells. These data argue against a human-specific role for LRP6 in anthrax toxin entry and suggest instead that involvement of this protein may be restricted to certain cell types independently of their species of origin.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus anthracis</italic>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Vitale1">[1]</xref>
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Chopra1">[3]</xref>
###xml 444 447 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Leppla1">[4]</xref>
###xml 577 580 577 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83 </sub>
###xml 586 588 586 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sub>
###xml 782 785 782 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Bradley1">[5]</xref>
###xml 787 790 787 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Scobie1">[6]</xref>
###xml 809 811 809 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 865 868 865 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Beauregard1">[7]</xref>
###xml 872 874 872 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63</sub>
###xml 912 917 912 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
###xml 952 955 952 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Milne1">[8]</xref>
###xml 1074 1077 1074 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Abrami1">[9]</xref>
###xml 1145 1150 1145 1150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
###xml 1214 1218 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Abrami2">[10]</xref>
###xml 1219 1223 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Krantz1">[12]</xref>
###xml 0 18 <span type="species:ncbi:1392">Bacillus anthracis</span>
###xml 45 52 <span type="species:ncbi:1392">anthrax</span>
###xml 128 135 <span type="species:ncbi:1392">Anthrax</span>
###xml 644 651 <span type="species:ncbi:1392">anthrax</span>
###xml 718 725 <span type="species:ncbi:1392">anthrax</span>
Bacillus anthracis, the etiological agent of anthrax, secretes a tripartite toxin, which is one of two major virulence factors. Anthrax toxin is composed of the receptor binding moiety, protective antigen (PA), and two catalytic moieties: Lethal factor (LF), a zinc -dependent metalloprotease that cleaves MAP kinase kinases (MAPKKs), [1]-[3] and edema factor (EF), a calcium- and calmodulin-dependent adenylate cyclase that raises cAMP levels [4]. LF and EF combine with PA to form lethal toxin (LeTx) and edema toxin (EdTx), respectively. Both 83 kD and 63 kD forms of PA (PA83 and PA63) can bind to either of two cellular receptors, ANTXR1 (anthrax toxin receptor 1/tumor endothelial marker 8; ATR/TEM8) or ANTXR2 (anthrax toxin receptor 2/capillary morphogenesis factor 2;CMG2) [5], [6]. Receptor-bound PA83 is cleaved by cell-surface furin into the 63 kD form [7]. PA63 forms a heptameric ring structure [PA63(7)], termed a prepore, at neutral pH [8]. EF and LF bind the prepore and the toxin/receptor complex is endocytosed primarily via clathrin-mediated endocytosis [9] and trafficked to an endocytic compartment where low-pH triggers PA63(7) pore formation and translocation of EF and LF into the cytosol [10]-[12].
###end p 4
###begin p 5
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Wei1">[13]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Wei1">[13]</xref>
###xml 520 531 520 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas</italic>
###xml 58 65 <span type="species:ncbi:1392">anthrax</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 1170 1175 <span type="species:ncbi:10090">mouse</span>
Currently there is a controversy about the role played in anthrax toxin entry by the low-density lipoprotein receptor-related protein LRP6, which interacts with both ANTXR1 and ANTXR2 [13]. Evidence in favor of a specific role was provided by Cohen and colleagues [13]. In that study, LRP6 was identified through a genome-wide antisense RNA screening approach to be important for intoxication of human M2182 prostate carcinoma cells by PA and FP59, a recombinant toxin comprised of the N-terminal portion of LF fused to Pseudomonas exotoxin A. Consistently, siRNA-mediated knockdown of LRP6 levels in these cells reduced their toxin sensitivity by several orders of magnitude, an effect that was partially overcome by expression of an siRNA-resistant form of LRP6. LRP6 deficiency in M2182 cells was also associated with reduced levels of PA binding and pore formation, and expression of a dominant-negative form of LRP6, lacking its cytoplasmic domain, rendered these cells resistant to intoxication. This group also showed that LRP6 could be co-precipitated with both ANTXR1 and ANTXR2. Furthermore, they showed that siRNA-mediated knockdown of LRP6 rendered RAW264.7 mouse macrophages resistant to intoxication by PA and LF, although this effect was much more modest (approximately3-fold) than that seen with M2182 cells. LRP6-specific antibodies also protected RAW264.7 cells from intoxication.
###end p 5
###begin p 6
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Young1">[14]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Brown1">[15]</xref>
###xml 299 302 299 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 310 313 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Young1">[14]</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 630 645 <span type="species:ncbi:10029">Chinese hamster</span>
By contrast, Duesbury and colleagues found that LRP6+/- and LRP5-/- mice were just as susceptible to killing after LeTx injection as wild-type mice [14]. LRP5 is a protein that is highly related to LRP6 [15]. In addition, they showed that mouse embryo fibroblasts (MEFs) that were isolated from LRP6-/- or LRP5-/- mice were just as susceptible to intoxication by PA and FP59, and to MEK1 cleavage by LF and PA, as those isolated from wild-type mice [14]. They went on to show that there is no obvious receptor-specific role for LRP6 since knocking down this protein had no effect on the toxin sensitivity of PA receptor-deficient Chinese hamster ovary cells that were engineered to express either ANTXR1 or ANTXR2.
###end p 6
###begin p 7
###xml 128 135 <span type="species:ncbi:1392">anthrax</span>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 482 489 <span type="species:ncbi:1392">anthrax</span>
###xml 507 512 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:9606">human</span>
###xml 599 606 <span type="species:ncbi:1392">anthrax</span>
Duesbury and colleagues put forward several possible explanations for the discrepant results. Since their data argue against an anthrax toxin receptor-specific role for LRP6, and there is no evidence for functional redundancy between LRP6 and LRP5 in toxin entry, they suggested that instead LRP6 might function in either a human-specific or cell type-specific manner. In this report we show that siRNA-mediated knockdown of LRP6 and/or LRP5 levels has no impact on the kinetics of anthrax toxin entry into human HeLa cells. These data argue against a human-specific role for either LRP6 or LRP5 in anthrax toxin entry and suggest that the requirement for LRP6 might be restricted to certain cell types.
###end p 7
###begin title 8
Results and Discussion
###end title 8
###begin title 9
Efficient siRNA-mediated knockdown of LRP6 and LRP5 expression in HeLa cells
###end title 9
###begin p 10
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Abrami1">[9]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Abrami3">[16]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Boll1">[17]</xref>
###xml 566 573 566 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g001">Fig. 1A</xref>
###xml 691 705 691 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g001">Fig. 1B and 1C</xref>
###xml 826 839 826 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g001">Fig. 1B and C</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 94 101 <span type="species:ncbi:1392">anthrax</span>
###xml 1119 1126 <span type="species:ncbi:1392">anthrax</span>
HeLa cells were chosen as a model human cell type because they have been used extensively for anthrax toxin entry studies and they are efficiently transfected with siRNAs [9], [16], [17]. To determine the efficiency of knocking down LRP6 or LRP5 expression, these cells were transfected with cognate siRNAs. These studies revealed an approximately 20-fold decrease in LRP5 and a 10-fold decrease in LRP6 mRNA transcripts in the transfected HeLa cells, relative to the levels observed with cells transfected with a negative control siRNA directed against luciferase (Fig. 1A). Consistently, siRNA transfection significantly reduced LRP5 and LRP6 proteins levels, as judged by immunoblotting (Fig. 1B and 1C). Importantly, LRP6 protein was reduced to undetectable levels in HeLa cells transfected with the corresponding siRNAs (Fig. 1B and C). Taken together these studies show that expression of LRP5 and LRP6 can be markedly reduced in siRNA-transfected HeLa cells. In addition, the level of siRNA-mediated knock-down of LRP5 and LRP6 exceeded those achieved in previous studies concerning the role of LRP5 and LRP6 in anthrax toxin internalization.
###end p 10
###begin title 11
siRNA knockdown of LRP5 and LPR6 mRNA and protein expression in HeLa cells.
###end title 11
###begin p 12
###xml 762 783 762 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">materials and methods</xref>
A) RT-PCR analysis of LRP5 and LRP6 levels in HeLa cells transfected either with cognate pools of siRNAs or with siRNAs directed against luciferase (negative control). These experiments were each performed with triplicate samples and the mean average results are shown along with the standard deviation of the data indicated by error bars. B) Immunoblot analysis of LRP5 and LRP6 protein levels in cells transfected with the pools of siRNAs described in panel A. To control for equivalent cellular protein levels imunoblot analysis was also conducted on tubulin. C) The relative levels of LRP5 and LRP6 proteins in each sample shown in panel B were quantitated relative to the levels of tubulin in each sample using the fluorescence-scanning method described in materials and methods.
###end p 12
###begin title 13
LRP6 and LRP5 are not important for intoxication of HeLa cells
###end title 13
###begin p 14
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">83</sub>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 241 242 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Milne2">[18]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Blanke1">[19]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Wesche1">[21]</xref>
###xml 936 942 936 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g002">Fig. 2</xref>
###xml 47 54 <span type="species:ncbi:1392">anthrax</span>
###xml 551 558 <span type="species:ncbi:1392">anthrax</span>
To test the importance of LRP6 and/or LRP5 for anthrax toxin entry, HeLa cells transfected with different siRNAs were tested for their susceptibility to intoxication in the presence of varied amounts of PA83 and a fixed amount of LFN-DTA. LFN-DTA is a hybrid toxin consisting of the PA-binding subunit of LF fused to the catalytic domain of diphtheria toxin A chain [18]. This recombinant toxin uses precisely the same PA-dependent pathway for cellular entry as that used by wild-type LF, and indeed it has been used as a convenient tool to study the anthrax toxin entry mechanism because, unlike wild-type LF, it can cause cell death in many cell types following its translocation into the cytosol [19]-[21]. For positive control purposes, HeLa cells were also transfected with siRNAs directed against both ANTXR1 and ANTXR2, which results in complete protection of the cells from intoxication because of efficient receptor knockdown (Fig. 2).
###end p 14
###begin title 15
Reduced levels of LRP6 and/or LRP5 do not influence the toxin sensitivity of HeLa cells.
###end title 15
###begin p 16
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
siRNA-transfected cells were incubated with varying amounts of PA83 (as shown) and with 5x10-10 M LFNDTA. These experiments were performed with triplicate samples and the results shown are the mean average values with the standard deviation of the data indicated with error bars.
###end p 16
###begin p 17
###xml 229 235 229 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g002">Fig. 2</xref>
###xml 313 320 <span type="species:ncbi:1392">anthrax</span>
These studies revealed that the cells transfected with LRP5- and/or LRP6-directed siRNAs were just as susceptible to intoxication as were untransfected cells or cells transfected with a control firefly luciferase-specific siRNA (Fig. 2). These data argue against a specific requirement for either LRP6 or LRP5 in anthrax toxin entry.
###end p 17
###begin title 18
###xml 49 54 49 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
LRP6 and LRP5 do not influence the kinetics of PA63(7) pore formation in HeLa cells
###end title 18
###begin p 19
###xml 39 45 39 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g002">Fig. 2</xref>
###xml 231 234 231 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Duesbery1">[2]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-OBrien1">[22]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Vitale2">[23]</xref>
###xml 376 379 376 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(7)</sub>
###xml 603 606 603 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(7)</sub>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Milne1">[8]</xref>
###xml 651 691 651 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Miller1">[XPATH ERROR: unknown variable "start".]</xref>
###xml 898 912 898 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g003">Fig. 3A and 3B</xref>
###xml 1030 1044 1030 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g003">Fig. 3A and 3B</xref>
The toxin sensitivity studies shown in Fig. 2 are conducted over a two day time frame and, as such, they do not provide any information on the kinetics of toxin entry which is usually complete within a 60- to 90-minute time period [2], [22], [23]. To explore the possibility that LRP6 and/or LRP5 might influence the kinetics of toxin entry we first evaluated the rate of PA63(7) pore formation in siRNA-transfected HeLa cells. Pore formation was evaluated during the first 35 minutes after initiating toxin internalization, using a standard approach, namely by the acid- pH-dependent conversion of PA63(7) to an SDS-resistant oligomeric species [8], [XPATH ERROR: unknown variable "start".], . These studies revealed that the kinetics of pore formation in cells transfected with LRP5 and/or LRP6 siRNAs were precisely the same as those seen in cells transfected with the control luciferase siRNA (Fig. 3A and 3B). As expected, HeLa cells treated with siRNAs targeting ANTXR1 and ANTXR2 showed little quantifiable pore formation (Fig. 3A and 3B). Taken together these studies demonstrate no obvious effect of knocking down LRP5 and/or LRP6 expression on the early kinetics of toxin uptake and acid pH-dependent PA pore formation.
###end p 19
###begin title 20
###xml 70 75 70 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
Reduced levels of LRP6 and/or LRP5 do not influence the kinetics of PA63(7) pore formation in HeLa cells.
###end title 20
###begin p 21
###xml 99 120 99 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">materials and methods</xref>
###xml 346 351 346 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
###xml 497 518 497 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">materials and methods</xref>
A) The kinetics of PA pore formation in siRNA-transfected HeLa cells was evaluated as described in materials and methods. The cells were lysed at different time points after initiating toxin entry (0, 15, 25, 35 mins) and the protein lysates subjected to SDS-PAGE and immunoblotting with anti-PA antibody to detect the SDS-resistant oligomeric PA63(7) pore species. (B) Quantitation of the levels of SDS-resistant pore species in the different time point samples shown in panel A. As described in materials and methods, the relative levels shown were determined by comparing the pore:tubulin ratio in each sample. The experiment shown is representative of three independent experiments.
###end p 21
###begin title 22
LRP6 and LRP5 do not influence the kinetics of MEK1 substrate cleavage in HeLa cells
###end title 22
###begin p 23
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Vitale1">[1]</xref>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Chopra1">[3]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Vitale2">[23]</xref>
###xml 813 827 813 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g004">Fig. 4A and 4B</xref>
###xml 962 976 962 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001817-g004">Fig. 4A and 4B</xref>
###xml 46 53 <span type="species:ncbi:1392">anthrax</span>
To confirm that LRP6 and LRP5 play no role in anthrax toxin entry into HeLa cells, we monitored the effect of knocking down expression of these proteins upon the kinetics of MEK1 cleavage by LF. LF cleavage removes the eight N-terminal amino acids of MEK1, an event that can be scored by immunoblotting using an antibody specific for the N-terminal region of MEK1 [1]-[3], [23]. MEK1 cleavage was monitored by immunoblotting at 0, 30, 45, 60, 75 and 90 minutes after LeTx addition and the signal obtained in each case was compared to that of Ku86, a cellular protein that is not a LF substrate. These studies revealed that siRNA-mediated knockdown of LRP6 or LRP5 levels had no influence on the MEK1 cleavage kinetics in HeLa cells (Compare these samples to the control samples transfected with luciferase siRNA: Fig. 4A and 4B). As expected, HeLa cells transfected with siRNAs targeting ANTXR1 and ANTXR2 were completely resistant to LF-mediated MEK1 cleavage (Fig. 4A and 4B).
###end p 23
###begin title 24
Reduced levels of LRP6 and/or LRP5 do not influence the kinetics of MEK1 cleavage in HeLa cells.
###end title 24
###begin p 25
A) HeLa cells transfected with different siRNAs were incubated with LeTx. Protein lysates were prepared at different time points and subjected to SDS-PAGE and immunoblotting with an anti-N-terminal MEK-1 antibody. Ku86, which is not an LF substrate, was also immunblotted as a loading control. B) The relative signal obtained with the N-terminal MEK1 antibody was compared with that associated with Ku86 in each sample shown in panel A. The experiment shown is representative of three independent experiments.
###end p 25
###begin p 26
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Young1">[14]</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 125 132 <span type="species:ncbi:1392">anthrax</span>
###xml 275 282 <span type="species:ncbi:1392">anthrax</span>
###xml 510 517 <span type="species:ncbi:1392">anthrax</span>
###xml 747 754 <span type="species:ncbi:1392">anthrax</span>
In summary, the data obtained in this report argue against a human specific role for LRP6 or for the related LRP5 protein in anthrax intoxication. Efficient siRNA-mediated knockdown of expression of either or both LRP5 and LRP6 in HeLa cells had no impact on the kinetics of anthrax toxin uptake or pore formation in acidic endosomes. Furthermore, these treatments did not alter the kinetics of MEK1 cleavage following LeTx uptake into HeLa cells. These data lead us to conclude that LRP6 may be important for anthrax toxin uptake in different cell types independently of their species of origin, as was suggested by Duesbury and colleagues [14]. However, future studies in this area will be required to clarify the precise context(s) under which anthrax toxin entry is dependent upon LRP6.
###end p 26
###begin title 27
Materials and Methods
###end title 27
###begin title 28
siRNA transfections
###end title 28
###begin p 29
###xml 196 217 196 217 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCAGAUAUCAGACGAAUUUUU</named-content>
###xml 219 240 219 240 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAGAUGAACUGGAUUGUUAUU</named-content>
###xml 242 263 242 263 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCACAGAGCGAUCACAUUAUU</named-content>
###xml 265 286 265 286 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCUCAACCGUGAAGUUAUAUU</named-content>
###xml 325 346 325 346 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGUCAAAGCCAUCGACUAUUU</named-content>
###xml 348 369 348 369 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGUCAUGGGUGGUGUCUAUUU</named-content>
###xml 371 392 371 392 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGACGGACCUACGGAGGAUUU</named-content>
###xml 394 416 394 416 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GUACAGGCCCUACAUCAUUUUU</named-content>
###xml 453 474 453 474 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCAGUGAGCAGAUUUAUUAUU</named-content>
###xml 476 497 476 497 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCUAAUAGGUCUCGAGAUCUU</named-content>
###xml 499 520 499 520 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAAGAAGUCCUGCAUCGAAUU</named-content>
###xml 522 543 522 543 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGAACAACCUUAAUGAAACUU</named-content>
###xml 589 609 589 609 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GUAAAGGCUUGGAGGAUUUU</named-content>
###xml 611 632 611 632 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCUAGCGAAUGAACAAAUUUU</named-content>
###xml 634 655 634 655 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGGCUAGUGUUUAUUGUGUUU</named-content>
###xml 657 678 657 678 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">UAUACUAGCUCAGUCAUGUUU</named-content>
###xml 735 755 735 755 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGTACGCGGAATACT TCGA</named-content>
HeLa cells were reverse-transfected using RNAiMax (Invitrogen) according to manufacturer's instructions with 32 nM siRNA. siRNAs were obtained from Dharmacon: LRP6 On-Target Plus SmartPool siRNA (GCAGAUAUCAGACGAAUUUUU, CAGAUGAACUGGAUUGUUAUU, CCACAGAGCGAUCACAUUAUU, GCUCAACCGUGAAGUUAUAUU) LRP5 On-Target Plus Smartpool siRNA (CGUCAAAGCCAUCGACUAUUU, CGUCAUGGGUGGUGUCUAUUU, GGACGGACCUACGGAGGAUUU, GUACAGGCCCUACAUCAUUUUU), ANTXR1 On Target SmartPool siRNA (CCAGUGAGCAGAUUUAUUAUU, GCUAAUAGGUCUCGAGAUCUU, GAAGAAGUCCUGCAUCGAAUU, GGAACAACCUUAAUGAAACUU) ANTXR2 On Target SmartPool siRNA (Dharmacon GUAAAGGCUUGGAGGAUUUU, GCUAGCGAAUGAACAAAUUUU, GGGCUAGUGUUUAUUGUGUUU, UAUACUAGCUCAGUCAUGUUU) and GL2 firefly luciferase siRNA (target DNA sequence: CGTACGCGGAATACT TCGA)
###end p 29
###begin title 30
LRP5 and LRP6 protein expression analysis
###end title 30
###begin p 31
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Rainey1">[24]</xref>
###xml 640 646 <span type="species:ncbi:9986">Rabbit</span>
###xml 952 956 <span type="species:ncbi:9925">goat</span>
###xml 962 968 <span type="species:ncbi:9986">rabbit</span>
###xml 990 994 <span type="species:ncbi:9925">goat</span>
###xml 1000 1006 <span type="species:ncbi:9986">rabbit</span>
Approximately 5x104 HeLa cells plated in individual wells of a 12-well plate were reverse-transfected with different siRNA pools targeting LRP5, LRP6, both LRP5 and LRP6, or firefly luciferase (negative control). After 48 hours, cells were lysed with reducing gel sample buffer containing 2% SDS and 100 mM DTT [24]. Lysate samples were separated by denaturing SDS-PAGE and transferred to PVDF membranes (Millipore). These membranes were blocked and incubated with antibodies in TBS-T containing 5% milk: The same conditions were used for all immunoblotting experiments described in this report. The antibodies used were the LRP5-specific (Rabbit anti-LRP5, Zymed) diluted 1:200 and the LRP6-specific (LRP6 C5C7), Cell Signaling Technologies) diluted 1:1000. Tubulin was detected as a loading control (alpha/beta-Tubulin antibody, Cell Signaling Technologies) diluted 1:1000. The Alexa Fluor 680-conjugated secondary antibody used in each case was the goat anti-rabbit IgG (Alexa Flour 680 goat anti-rabbit IgG, Invitrogen) diluted 1:20,000. The samples were then scanned and analyzed with the fluorescence-scanning Odyssey system and its associated software (Li-Cor).
###end p 31
###begin title 32
RT-PCR analysis of LRP5 and LRP6 mRNA expression
###end title 32
###begin p 33
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 852 874 828 850 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCTCTGACTTCAACAGCGACAC</named-content>
###xml 876 897 852 873 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTCCTCTTGTGCTCTTGCTGG</named-content>
Approximately 1x105 HeLa cells plated in individual wells of a 6-well plate were reverse-transfected with the different siRNA pools described above. RNA was harvested using the Qiagen RNeasy kit at 48 hours post siRNA transfection for RT-PCR analysis: The cDNA synthesis was performed with the SuperScript III reverse transcriptase system (Invitrogen) using 2 microg of total RNA from each sample and random hexamers as primers. PCR amplification was subsequently performed for 40 cycles (95degreesC for 15 seconds, 60degreesC for 1 minute) with an ABI Prism 7900HT instrument and with primers obtained from the validated library of Qiagen Quantitect primers along with Sybr green PCR master mix (Applied Biosystems). The relative levels of LRP5 or LRP6 mRNA transcripts were then determined using the Comparative Ct (DeltaDeltaCt) method using GAPDH (CCTCTGACTTCAACAGCGACAC, TTCCTCTTGTGCTCTTGCTGG) as an endogenous mRNA control.
###end p 33
###begin title 34
Cell intoxication assays
###end title 34
###begin p 35
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 204 205 204 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Milne2">[18]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Rainey1">[24]</xref>
Triplicate samples of approximately 5x103 HeLa cells seeded in individual wells of a 96-well plate were reverse-transfected with the different siRNAs. After 48 hours, cells were incubated with 5x10-10M LFN-DTA and with varying concentrations of PA for 48 hours [18]. Cell viability was then assayed with the Cell Titer-Glo assay (Promega) as previously described [24].
###end p 35
###begin title 36
SDS-resistant pore formation
###end title 36
###begin p 37
###xml 33 38 33 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">63(7)</sub>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Rainey1">[24]</xref>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 401 405 <span type="species:ncbi:9925">Goat</span>
###xml 519 525 <span type="species:ncbi:9986">rabbit</span>
###xml 531 535 <span type="species:ncbi:9925">goat</span>
Formation of the SDS-resistant PA63(7) pore species was detected by immunoblotting as previously described [24], except cells were incubated with 2.5x10-8M PA and 2x10-9M LF for 2 hours at 4degreesC, washed and shifted to 37degreesC for the indicated times. Cells were lysed with reducing gel sample buffer, protein lysates were subjected to SDS-PAGE and SDS-resistant pore was detected with anti-PA (Goat anti-PA, List Labs) diluted 1:2,000. The secondary antibody used in this case was the Alexa Fluor-680 conjugated rabbit anti-goat (Invitrogen) diluted 1:20,000. The immunoblotting conditions were the same as described above and western blot scanning and analysis was conducted using the Odyssey system and its associated software (LiCor).
###end p 37
###begin title 38
MEK1 Cleavage assays
###end title 38
###begin p 39
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001817-Rainey1">[24]</xref>
###xml 492 498 <span type="species:ncbi:9986">Rabbit</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
MEK1 cleavage was detected by immunoblotting as previously described [24], except that samples were collected directly with reducing gel sample buffer. Membrane blocking and antibody dilutions were performed with TBS-T containing 5% milk as described above. The N-terminal MEK1 antibody (Anti-MEK1 N-terminal) was obtained from Calbiochem (used at 1:1,000) and the Ku86 antibody (Ku-86 B-1) was obtained from Santa Cruz Biotechnology (used at 1:500 dilution). Alexa Fluor-680 conjugated anti-Rabbit IgG and Alexa Fluor-680 conjugated anti-mouse IgG (Invitrogen) were used as secondary antibodies (both diluted 1:20,000). Western blot scanning and analysis was conducted using the Odyssey system and its associated software (LiCor).
###end p 39
###begin p 40
We thank members of the Young lab for helpful discussions, especially John Naughton who helped prepare the figures.
###end p 40
###begin title 41
References
###end title 41
###begin article-title 42
###xml 91 98 <span type="species:ncbi:1392">anthrax</span>
Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.
###end article-title 42
###begin article-title 43
###xml 49 56 <span type="species:ncbi:1392">anthrax</span>
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
###end article-title 43
###begin article-title 44
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax lethal factor proteolysis and inactivation of MAPK kinase.
###end article-title 44
###begin article-title 45
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
###end article-title 45
###begin article-title 46
###xml 44 51 <span type="species:ncbi:1392">anthrax</span>
Identification of the cellular receptor for anthrax toxin.
###end article-title 46
###begin article-title 47
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 56 63 <span type="species:ncbi:1392">anthrax</span>
Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
###end article-title 47
###begin article-title 48
###xml 41 48 <span type="species:ncbi:1392">anthrax</span>
Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization.
###end article-title 48
###begin article-title 49
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax protective antigen forms oligomers during intoxication of mammalian cells.
###end article-title 49
###begin article-title 50
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.
###end article-title 50
###begin article-title 51
###xml 22 29 <span type="species:ncbi:1392">anthrax</span>
Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway.
###end article-title 51
###begin article-title 52
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax protective antigen: prepore-to-pore conversion.
###end article-title 52
###begin article-title 53
###xml 66 73 <span type="species:ncbi:1392">anthrax</span>
A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore.
###end article-title 53
###begin article-title 54
###xml 80 87 <span type="species:ncbi:1392">anthrax</span>
The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
###end article-title 54
###begin article-title 55
###xml 95 102 <span type="species:ncbi:1392">Anthrax</span>
LRP5 and LRP6 Are Not Required for Protective Antigen-Mediated Internalization or Lethality of Anthrax Lethal Toxin.
###end article-title 55
###begin article-title 56
Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family.
###end article-title 56
###begin article-title 57
###xml 52 59 <span type="species:ncbi:1392">anthrax</span>
Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.
###end article-title 57
###begin article-title 58
###xml 47 54 <span type="species:ncbi:1392">anthrax</span>
Effects of dynamin inactivation on pathways of anthrax toxin uptake.
###end article-title 58
###begin article-title 59
###xml 37 44 <span type="species:ncbi:1392">anthrax</span>
Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus.
###end article-title 59
###begin article-title 60
###xml 107 114 <span type="species:ncbi:1392">anthrax</span>
Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen.
###end article-title 60
###begin article-title 61
###xml 72 79 <span type="species:ncbi:1392">anthrax</span>
Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
###end article-title 61
###begin article-title 62
###xml 46 53 <span type="species:ncbi:1392">anthrax</span>
Characterization of membrane translocation by anthrax protective antigen.
###end article-title 62
###begin article-title 63
###xml 11 18 <span type="species:ncbi:1392">anthrax</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
Effects of anthrax toxin components on human neutrophils.
###end article-title 63
###begin article-title 64
###xml 0 7 <span type="species:ncbi:1392">Anthrax</span>
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
###end article-title 64
###begin article-title 65
###xml 35 42 <span type="species:ncbi:1392">anthrax</span>
Receptor-specific requirements for anthrax toxin delivery into cells.
###end article-title 65
###begin p 66
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 36 48 <span type="species:ncbi:3724">common stock</span>
Competing Interests: J.A.T.Y. holds common stock in PharmAthene, Inc.
###end p 66
###begin p 67
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grant AI48489.
###end p 67

